semaglutide vomiting after eating Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its side effects range from common GI symptoms to rare but serious risks. ⸻ 🟡 Common Rybelsus: Side Effects and How

Rejuvenation research

That's not a marketing line

Tirzepatides recent market entry resulted in smaller sample sizes, potentially reducing power to detect subtle ocular changes

doi: 10.1038/s41467-024-45710-4 71 ZengXMaQLiXKYouLTLiJFuXet al

Endothelial overexpression of metallothionein prevents diabetes-induced impairment in ischemia angiogenesis through preservation of HIF-1 alpha/SDF-1/VEGF signaling in endothelial progenitor cells

Biopsy-proven NASH : Patients with histologically confirmed NASH, particularly those with significant inflammation or early fibrosis (F1-F2), may be considered for off-label GLP-1 therapy, especially if they have failed lifestyle modification or have contraindications to other therapies like vitamin E or pioglitazone